| pubmed-article:19808265 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19808265 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:19808265 | lifeskim:mentions | umls-concept:C0029921 | lld:lifeskim |
| pubmed-article:19808265 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:19808265 | lifeskim:mentions | umls-concept:C0018801 | lld:lifeskim |
| pubmed-article:19808265 | lifeskim:mentions | umls-concept:C0054015 | lld:lifeskim |
| pubmed-article:19808265 | lifeskim:mentions | umls-concept:C0036043 | lld:lifeskim |
| pubmed-article:19808265 | lifeskim:mentions | umls-concept:C1522577 | lld:lifeskim |
| pubmed-article:19808265 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:19808265 | lifeskim:mentions | umls-concept:C0574032 | lld:lifeskim |
| pubmed-article:19808265 | lifeskim:mentions | umls-concept:C0332466 | lld:lifeskim |
| pubmed-article:19808265 | lifeskim:mentions | umls-concept:C0031082 | lld:lifeskim |
| pubmed-article:19808265 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
| pubmed-article:19808265 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:19808265 | pubmed:dateCreated | 2009-10-7 | lld:pubmed |
| pubmed-article:19808265 | pubmed:databankReference | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19808265 | pubmed:abstractText | Patients with American College of Cardiology/American Heart Association stage C/D heart failure experience substantial morbidity and mortality, but available interventions beyond standard medical and device therapies are limited. Nesiritide relieves dyspnea and reduces pulmonary congestion, but its risk profile is uncertain. Pilot data suggested a potential benefit of nesiritide given as serial outpatient infusions. | lld:pubmed |
| pubmed-article:19808265 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19808265 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19808265 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19808265 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19808265 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19808265 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19808265 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19808265 | pubmed:month | May | lld:pubmed |
| pubmed-article:19808265 | pubmed:issn | 1941-3297 | lld:pubmed |
| pubmed-article:19808265 | pubmed:author | pubmed-author:MassieBarry... | lld:pubmed |
| pubmed-article:19808265 | pubmed:author | pubmed-author:YancyClyde... | lld:pubmed |
| pubmed-article:19808265 | pubmed:author | pubmed-author:StevensonLynn... | lld:pubmed |
| pubmed-article:19808265 | pubmed:author | pubmed-author:SilverMarc... | lld:pubmed |
| pubmed-article:19808265 | pubmed:author | pubmed-author:KrumHenryH | lld:pubmed |
| pubmed-article:19808265 | pubmed:author | pubmed-author:KimSun SookSS | lld:pubmed |
| pubmed-article:19808265 | pubmed:author | pubmed-author:ChengMeiM | lld:pubmed |
| pubmed-article:19808265 | pubmed:author | pubmed-author:FUSION II... | lld:pubmed |
| pubmed-article:19808265 | pubmed:author | pubmed-author:EvansRosemary... | lld:pubmed |
| pubmed-article:19808265 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19808265 | pubmed:volume | 1 | lld:pubmed |
| pubmed-article:19808265 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19808265 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19808265 | pubmed:pagination | 9-16 | lld:pubmed |
| pubmed-article:19808265 | pubmed:meshHeading | pubmed-meshheading:19808265... | lld:pubmed |
| pubmed-article:19808265 | pubmed:meshHeading | pubmed-meshheading:19808265... | lld:pubmed |
| pubmed-article:19808265 | pubmed:meshHeading | pubmed-meshheading:19808265... | lld:pubmed |
| pubmed-article:19808265 | pubmed:meshHeading | pubmed-meshheading:19808265... | lld:pubmed |
| pubmed-article:19808265 | pubmed:meshHeading | pubmed-meshheading:19808265... | lld:pubmed |
| pubmed-article:19808265 | pubmed:meshHeading | pubmed-meshheading:19808265... | lld:pubmed |
| pubmed-article:19808265 | pubmed:meshHeading | pubmed-meshheading:19808265... | lld:pubmed |
| pubmed-article:19808265 | pubmed:meshHeading | pubmed-meshheading:19808265... | lld:pubmed |
| pubmed-article:19808265 | pubmed:meshHeading | pubmed-meshheading:19808265... | lld:pubmed |
| pubmed-article:19808265 | pubmed:meshHeading | pubmed-meshheading:19808265... | lld:pubmed |
| pubmed-article:19808265 | pubmed:meshHeading | pubmed-meshheading:19808265... | lld:pubmed |
| pubmed-article:19808265 | pubmed:meshHeading | pubmed-meshheading:19808265... | lld:pubmed |
| pubmed-article:19808265 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:19808265 | pubmed:articleTitle | Safety and efficacy of outpatient nesiritide in patients with advanced heart failure: results of the Second Follow-Up Serial Infusions of Nesiritide (FUSION II) trial. | lld:pubmed |
| pubmed-article:19808265 | pubmed:affiliation | Baylor University Medical Center, Heart and Vascular Institute, Dallas, TX 75246, USA. clydey@baylorhealth.edu | lld:pubmed |
| pubmed-article:19808265 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19808265 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:19808265 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19808265 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19808265 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19808265 | lld:pubmed |
